Pages that link to "Q35156549"

The following pages link to Polyglutamine Disease Modeling: Epitope Based Screen for Homologous Recombination using CRISPR/Cas9 System (Q35156549):

Displaying 22 items.

• Genome Engineering with TALE and CRISPR Systems in Neuroscience (Q26752488) (← links)
• Genome Editing Using Mammalian Haploid Cells (Q26782077) (← links)
• Cellular reprogramming for understanding and treating human disease (Q34496408) (← links)
• The iCRISPR platform for rapid genome editing in human pluripotent stem cells (Q35567360) (← links)
• Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy (Q37652595) (← links)
• Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells. (Q37707514) (← links)
• iPSC-based drug screening for Huntington's disease (Q38597179) (← links)
• The application of CRISPR technology to high content screening in primary neurons (Q38767473) (← links)
• Gene correction in patient-specific iPSCs for therapy development and disease modeling (Q38852141) (← links)
• Modeling simple repeat expansion diseases with iPSC technology. (Q38853911) (← links)
• Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity (Q38884155) (← links)
• Modern Genome Editing Technologies in Huntington's Disease Research (Q39106522) (← links)
• Genome editing: a robust technology for human stem cells (Q39239599) (← links)
• The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders (Q49335959) (← links)
• Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease (Q49478512) (← links)
• Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases. (Q52430802) (← links)
• Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech (Q60912966) (← links)
• Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease (Q63246542) (← links)
• Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells (Q64947331) (← links)
• Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models (Q90140618) (← links)
• Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology (Q90393662) (← links)
• Progress in understanding Friedreich's ataxia using human induced pluripotent stem cells (Q92089407) (← links)